These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 14631045)

  • 1. Diverse psychotomimetics act through a common signaling pathway.
    Svenningsson P; Tzavara ET; Carruthers R; Rachleff I; Wattler S; Nehls M; McKinzie DL; Fienberg AA; Nomikos GG; Greengard P
    Science; 2003 Nov; 302(5649):1412-5. PubMed ID: 14631045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychotomimetic effects of drugs--a common pathway to schizophrenia?
    Gerber DJ; Tonegawa S
    N Engl J Med; 2004 Mar; 350(10):1047-8. PubMed ID: 14999118
    [No Abstract]   [Full Text] [Related]  

  • 3. Dopamine D3 receptor deletion increases tissue plasminogen activator (tPA) activity in prefrontal cortex and hippocampus.
    Castorina A; D'Amico AG; Scuderi S; Leggio GM; Drago F; D'Agata V
    Neuroscience; 2013 Oct; 250():546-56. PubMed ID: 23906635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comment on "Diverse psychotomimetics act through a common signaling pathway".
    Seeman P
    Science; 2004 Jul; 305(5681):180; author reply 180. PubMed ID: 15247457
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32.
    Dunah AW; Sirianni AC; Fienberg AA; Bastia E; Schwarzschild MA; Standaert DG
    Mol Pharmacol; 2004 Jan; 65(1):121-9. PubMed ID: 14722243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DARPP-32: regulator of the efficacy of dopaminergic neurotransmission.
    Fienberg AA; Hiroi N; Mermelstein PG; Song W; Snyder GL; Nishi A; Cheramy A; O'Callaghan JP; Miller DB; Cole DG; Corbett R; Haile CN; Cooper DC; Onn SP; Grace AA; Ouimet CC; White FJ; Hyman SE; Surmeier DJ; Girault J; Nestler EJ; Greengard P
    Science; 1998 Aug; 281(5378):838-42. PubMed ID: 9694658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative changes in Galphaolf protein levels, but not D1 receptor, alter specifically acute responses to psychostimulants.
    Corvol JC; Valjent E; Pascoli V; Robin A; Stipanovich A; Luedtke RR; Belluscio L; Girault JA; Hervé D
    Neuropsychopharmacology; 2007 May; 32(5):1109-21. PubMed ID: 17063155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal exposure to cocaine disrupts D1A dopamine receptor function via selective inhibition of protein phosphatase 1 pathway in rabbit frontal cortex.
    Zhen X; Torres C; Wang HY; Friedman E
    J Neurosci; 2001 Dec; 21(23):9160-7. PubMed ID: 11717349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of spinophilin Ser94 phosphorylation in neostriatal neurons involves both DARPP-32-dependent and independent pathways.
    Uematsu K; Futter M; Hsieh-Wilson LC; Higashi H; Maeda H; Nairn AC; Greengard P; Nishi A
    J Neurochem; 2005 Dec; 95(6):1642-52. PubMed ID: 16300646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonistic effects of dopaminergic signaling and ethanol on protein kinase A-mediated phosphorylation of DARPP-32 and the NR1 subunit of the NMDA receptor.
    Edwards S; Simmons DL; Galindo DG; Doherty JM; Scott AM; Hughes PD; Wilcox RE
    Alcohol Clin Exp Res; 2002 Feb; 26(2):173-80. PubMed ID: 11964556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum.
    Valjent E; Pascoli V; Svenningsson P; Paul S; Enslen H; Corvol JC; Stipanovich A; Caboche J; Lombroso PJ; Nairn AC; Greengard P; Hervé D; Girault JA
    Proc Natl Acad Sci U S A; 2005 Jan; 102(2):491-6. PubMed ID: 15608059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D1-Receptor, DARPP-32, and PP-1 in the primate corpus luteum and luteinized granulosa cells: evidence for phosphorylation of DARPP-32 by dopamine and human chorionic gonadotropin.
    Mayerhofer A; Fritz S; Grünert R; Sanders SL; Duffy DM; Ojeda SR; Stouffer RL
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4750-7. PubMed ID: 11134138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of protein phosphatase-1 inhibitors, inhibitor-1 and DARPP-32, in renal medulla.
    Higuchi E; Nishi A; Higashi H; Ito Y; Kato H
    Eur J Pharmacol; 2000 Nov; 408(2):107-16. PubMed ID: 11080516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices.
    Halpain S; Girault JA; Greengard P
    Nature; 1990 Jan; 343(6256):369-72. PubMed ID: 2153935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling.
    Nishi A; Liu F; Matsuyama S; Hamada M; Higashi H; Nairn AC; Greengard P
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1322-7. PubMed ID: 12538871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor Skill Learning Is Associated with Phase-Dependent Modifications in the Striatal cAMP/PKA/DARPP-32 Signaling Pathway in Rodents.
    Qian Y; Forssberg H; Diaz Heijtz R
    PLoS One; 2015; 10(10):e0140974. PubMed ID: 26488498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroscience. A kinase to dampen the effects of cocaine?
    Gupta A; Tsai LH
    Science; 2001 Apr; 292(5515):236-7. PubMed ID: 11305318
    [No Abstract]   [Full Text] [Related]  

  • 18. DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1.
    Hemmings HC; Greengard P; Tung HY; Cohen P
    Nature; 1984 Aug 9-15; 310(5977):503-5. PubMed ID: 6087160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mesolimbic dopaminergic response to novel palatable food consumption increases dopamine-D1 receptor-mediated signalling with complex modifications of the DARPP-32 phosphorylation pattern.
    Rauggi R; Scheggi S; Cassanelli A; De Montis MG; Tagliamonte A; Gambarana C
    J Neurochem; 2005 Feb; 92(4):867-77. PubMed ID: 15686489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DARPP-32 and modulation of cAMP signaling: involvement in motor control and levodopa-induced dyskinesia.
    Håkansson K; Lindskog M; Pozzi L; Usiello A; Fisone G
    Parkinsonism Relat Disord; 2004 Jul; 10(5):281-6. PubMed ID: 15196506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.